Pharsight

Drugs that contain Dimethyl Fumarate

1. Tecfidera patents expiration

TECFIDERA's oppositions filed in EPO
TECFIDERA Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8399514 BIOGEN INC Treatment for multiple sclerosis
Feb, 2028

(3 years from now)

US10994003 BIOGEN INC Dimethyl fumarate and vaccination regimens
Mar, 2035

(11 years from now)

US10555993 BIOGEN INC Dimethyl fumarate and vaccination regimens
Mar, 2035

(11 years from now)

US10391160 BIOGEN INC Dimethyl fumarate and vaccination regimens
Mar, 2035

(11 years from now)

US11007167 BIOGEN INC Methods of treating multiple sclerosis
Nov, 2035

(11 years from now)

US11246850 BIOGEN INC Methods of treating multiple sclerosis
Nov, 2035

(11 years from now)

US10959972 BIOGEN INC Methods of treating multiple sclerosis
Nov, 2035

(11 years from now)

US11129806 BIOGEN INC Methods of treating multiple sclerosis
Nov, 2035

(11 years from now)

US11007166 BIOGEN INC Methods of treating multiple sclerosis
Nov, 2035

(11 years from now)

Drug Exclusivity Drug Exclusivity Expiration
M (M) Feb 5, 2023

Market Authorisation Date: 27 March, 2013

Treatment: Method of treating multiple sclerosis; Method of treating relapsing forms of multiple sclerosis before and after administering an inactive vaccine

Dosage: CAPSULE, DELAYED RELEASE;ORAL

How can I launch a generic of TECFIDERA before it's drug patent expiration?
More Information on Dosage

TECFIDERA family patents

Family Patents